Mathieu Chevrier

Stock Analyst at Citigroup

(2.35)
# 2,339
Out of 4,829 analysts
2
Total ratings
100%
Success rate
8.26%
Average return
Main Sectors:

Stocks Rated by Mathieu Chevrier

ResMed
Mar 5, 2025
Upgrades: Buy
Price Target: n/a
Current: $247.66
Upside: -